DuPont de Nemours, Inc. logo

DuPont de Nemours, Inc. (DD)

Market Open
21 Jul, 16:46
NYSE NYSE
$
139. 16
+3.41
+2.512%
$
18.12B Market Cap
37.17 P/E Ratio
3.92% Div Yield
402,142 Volume
4.3 Eps
$ 135.75
Previous Close
Add Transaction
Day Range
135.52 139.4
Year Range
86.59 157.98
Want to track DD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why DuPont de Nemours (DD) is a Top Dividend Stock for Your Portfolio

Why DuPont de Nemours (DD) is a Top Dividend Stock for Your Portfolio

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does DuPont de Nemours (DD) have what it takes?

Zacks | 1 year ago
DuPont Is Again in China's Firing Line in Trade War 2.0

DuPont Is Again in China's Firing Line in Trade War 2.0

Shortly after President Trump announced an increase in tariffs on U.S. imports from China, regulators in Beijing unveiled a probe of DuPont, alleging unspecified monopolistic behavior.

Wsj | 1 year ago
Strength Seen in DuPont de Nemours (DD): Can Its 12.4% Jump Turn into More Strength?

Strength Seen in DuPont de Nemours (DD): Can Its 12.4% Jump Turn into More Strength?

DuPont de Nemours (DD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks | 1 year ago
Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

DD gains on its focus on growth through innovation, acquisitions and productivity actions amid pricing and cost headwinds.

Zacks | 1 year ago
Nonfarm Payrolls Exceed Expectations in March

Nonfarm Payrolls Exceed Expectations in March

Nonfarm Payrolls Exceed Expectations in March.

Zacks | 1 year ago
DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing

DuPont Introduces Liveo Pharma TPE Ultra-Low Temp Tubing

DD brings Liveo Pharma TPE Ultra-Low Temp Tubing into the market for biopharmaceutical processing applications.

Zacks | 1 year ago
DuPont Gains on Productivity & Innovation Amid Pricing Woes

DuPont Gains on Productivity & Innovation Amid Pricing Woes

While DD faces pricing and cost headwinds, it gains on its focus on growth through innovation, acquisitions and productivity actions.

Zacks | 1 year ago
DuPont de Nemours (DD) is a Top Dividend Stock Right Now: Should You Buy?

DuPont de Nemours (DD) is a Top Dividend Stock Right Now: Should You Buy?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does DuPont de Nemours (DD) have what it takes?

Zacks | 1 year ago
DuPont Introduces Cutting-Edge Advanced Circuit Materials in Shanghai

DuPont Introduces Cutting-Edge Advanced Circuit Materials in Shanghai

DD is applying its decades of expertise in material science to meet the growing needs of the rapidly expanding IC substrate and high-end PCB market.

Zacks | 1 year ago
DuPont insider Jon Kemp to lead electronics unit post spinoff

DuPont insider Jon Kemp to lead electronics unit post spinoff

Chemicals firm DuPont De Nemours said on Monday insider Jon Kemp will take over as CEO of its independent electronics unit following the planned spinoff of the business.

Reuters | 1 year ago
Why Is DuPont de Nemours (DD) Down 7.7% Since Last Earnings Report?

Why Is DuPont de Nemours (DD) Down 7.7% Since Last Earnings Report?

DuPont de Nemours (DD) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Here's Why You Should Retain DuPont Stock in Your Portfolio

Here's Why You Should Retain DuPont Stock in Your Portfolio

DD gains on its focus on growth through innovation, acquisitions and productivity actions amid pricing and cost headwinds.

Zacks | 1 year ago
Loading...
Load More